Effects of 2-Week Treatment With Temazepam and Diphenhydramine in Elderly Insomniacs: A Randomized, Placebo-Controlled Trial
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
A randomized, controlled, crossover clinical study compared 14-night treatment with 15 mg temazepam, 50 mg diphenhydramine, and placebo in elderly individuals with insomnia (mean age, 73.9 years; range, 70-89 years). Primary outcome measures were subjective assessments of sleep recorded on sleep diaries. Secondary measures were the morning-after psychomotor impairment, using the digit symbol substitution task and the manual tracking task, and the morning-after memory impairment, using a free-recall procedure. Results showed sleep improvements with 15 mg temazepam compared with placebo-sleep quality (mean score, 3.3 +/- 0.9 vs 2.9 +/- 0.8; P = 0.03), total sleep time (6.9 +/- 1.0 hours vs 6.3 +/-1.3 hours; P = 0.02), number of awakenings (1.5 +/- 1.3 vs 2.0 +/- 1.2; P < 0.001), and sleep-onset latency (25 +/- 22 minutes vs 37 +/- 25 minutes; P = 0.03). Improvements were seen with diphenhydramine treatment compared with placebo on the number of awakenings only (mean, 1.7 +/- 1.1 vs 2.0 +/- 1.2; P < 0.05). Numbers of adverse events reported were similar after all treatments, although there was 1 fall during temazepam treatment. Findings indicate that temazepam is more effective than diphenhydramine when compared with placebo at the doses tested, although this advantage is mitigated by the risk of falls associated with temazepam use. The choice of agent to use in the elderly must consider these relative benefits and risks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
What's wrong with Bonferroni adjustments
Perneger, T. V. (1998) · BMJ · doi:10.1136/bmj.316.7139.1236 · Cited by 5,900
Epidemiology of insomnia: what we know and what we still need to learn
Ohayon, M. M. (2002) · Sleep Medicine Reviews · doi:10.1053/smrv.2002.0186 · Cited by 3,743 · cited 1×
“Approximately 40% to 50% of the general population in North America and Europe display symptoms of insomnia.(1,2) In addition to being a common problem, insomnia has a negative impact on ability to function(3,4) and overall health”
BackgroundSedative hypnotics in older people with insomnia: meta-analysis of risks and benefits
Glass, J., Lanctôt, K. L., Herrmann, N., Sproule, B. A., & Busto, U. E. (2005) · BMJ · doi:10.1136/bmj.38623.768588.47 · Cited by 1,161 · cited 1×
“Results with 15 mg temazepam are remarkably similar compared with results from a meta-analysis performed in elderly individuals.(40) For example, in the present study, the mean change in total sleep time with temazepam was 36 minutes compared with 34.”
ResultSelf-citationComparative Meta-Analysis of Pharmacotherapy and Behavior Therapy for Persistent Insomnia
Smith, M. T., Perlis, M. L., Park, A., Smith, M. S., Pennington, J., Giles, D. E., & Buysse, D. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.1.5 · Cited by 863 · cited 1×
“Benzodiazepines have consistently been shown effective for insomnia at least in the short term.(13,14) However, they are also associated with negative side effects, such as ataxia, memory impairment (anterograde amnesia), falls, and increases in motor vehicle accidents.”
BackgroundMedical and socio-professional impact of insomnia
Léger, D., Guilleminault, C., Bader, G., Lévy, E., & Paillard, M. (2002) · Sleep · doi:10.1093/sleep/25.6.621 · Cited by 468
SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers
Léger, D., Scheuermaier, K., Philip, P., Paillard, M., & Guilleminault, C. (2001) · Psychosomatic Medicine · doi:10.1097/00006842-200101000-00006 · Cited by 377 · cited 1×
“Insomniacs are more likely to use health care services, such as physician time,(5,6) and to score lower on quality-of-life questionnaires.(7,8) Insomnia has been associated with high societal costs.”
BackgroundSensitivity to triazolam in the elderly
Greenblatt, D. J., Harmatz, J. S., Shapiro, L., Engelhardt, N., Gouthro, T. A., & Shader, R. I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106133242403 · Cited by 258
Morin, C. M., Koetter, U., Bastien, C., Ware, J. C., & Wooten, V. (2005) · Sleep · doi:10.1093/sleep/28.11.1465 · Cited by 190 · cited 2×
“Diphenhydramine has been shown to have little effect on sleep architecture (Stages 3 and 4 or deep sleep), which may explain the lack of effect on sleep quality.(37) Results with 15 mg temazepam are remarkably similar compared with results from a meta-analysis performed in elderly individuals.”
ResultBenzodiazepines with different half-life and falling in a hospitalized population
Passaro, A., Volpato, S., Romagnoni, F., Manzoli, N., Zuliani, G., & Fellin, R. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00254-7 · Cited by 122
Cited by
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Review of Safety and Efficacy of Sleep Medicines in Older Adults
Schroeck, J. L., Ford, J., Conway, E. L., Kurtzhalts, K. E., Gee, M. E., Vollmer, K. A., & Mergenhagen, K. A. (2016) · Clinical Therapeutics · doi:10.1016/j.clinthera.2016.09.010 · Cited by 373
The assessment and management of insomnia: an update
Krystal, A. D., Prather, A. A., & Ashbrook, L. H. (2019) · World Psychiatry · doi:10.1002/wps.20674 · Cited by 256
Winkelman, J. W. (2015) · New England Journal of Medicine · doi:10.1056/nejmcp1412740 · Cited by 232
Relationship between the use of benzodiazepines and falls in older adults: a systematic review
Díaz-Gutiérrez, M. J., Martínez-Cengotitabengoa, M., Sáez de Adana, E., Cano, A. I., Martínez-Cengotitabengoa, M. T., Besga, A., Segarra, R., & González-Pinto, A. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.04.002 · Cited by 131
2023 Guidelines on the Diagnosis and Treatment of Insomnia in Adults - Brazilian Sleep Association
Drager, L. F., Assis, M., Bacelar, A. F. R., Poyares, D. L. R., Conway, S. G., Pires, G. N., de Azevedo, A. P., Carissimi, A., Eckeli, A. L., Pentagna, Á., et al. (2023) · Sleep Science · doi:10.1055/s-0043-1776281 · Cited by 25
“271,272 Off-label use of this class can generate residual symptoms the next day and compromise everyday situations (re fl exes, ability to drive, etc.).”
Background
Metadata
- Authors
- Glass, J. R., Sproule, B. A., Herrmann, N., & Busto, U. E.
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2008-04
- Volume
- 28
- Issue
- 2
- Pages
- 182-188
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2074908833
- Cited by
- 92
- References
- 9
- FWCI
- 6.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.